H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications
Giuseppe Angelico(Università degli Studi di Enna Kore), Giuseppe Broggi(University of Catania), Maurizio Zizzo(Azienda Sanitaria Unità Locale di Reggio Emilia), Nektarios Koufopoulos(National and Kapodistrian University of Athens), Francesco Certo(University of Catania), Giordana Tinnirello(University of Catania), Alessandra Bisagni(Ospedale Santa Maria), Giuseppe Barbagallo(University of Catania), Manuel Mazzucchelli(University of Catania), Rosario Caltabiano(University of Catania), Magda Zanelli(Azienda Sanitaria Unità Locale di Reggio Emilia), Andrea Palicelli(Azienda Sanitaria Unità Locale di Reggio Emilia), Jessica Farina(University of Catania), Giulio Attanasio(University of Catania), Gaetano Magro(University of Catania)
Cited by 8
Related Papers
CircSMARCA5 Regulates VEGFA mRNA Splicing and Angiogenesis in Glioblastoma Multiforme Through the Binding of SRSF1
|Cancers|2019|230
Surgical Treatment of Spasticity in Cerebral Palsy
|Pediatric Neurosurgery|1978|166
Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme
|Pharmaceuticals|2021|108
Practical Approach to Histological Diagnosis of Peripheral Nerve Sheath Tumors: An Update
|Diagnostics|2022|103
Protection from experimental autoimmune diabetes in the non‐obese diabetic mouse with soluble interleukin‐1 receptor
|European Journal of Immunology|1994|87